{"name":"Metabolic Solutions Development Company","slug":"metabolic-solutions-development-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNbUZtNUZieHhSUkVWSHhoVTFwdm9TQnpNc1R5QThsaHBod2E2dTJxOUwtZXdFenhnM2h1VWtBdEgwTEFYOGd0VXFybTc5TlhzMEg5SFJDRXZkbDQ4UjkxLUFid2NxbGJ2c3psa1AybEhFM1dQTHQzY29XSUJ0UWtPZl9mYXlHRjY5dDlxQkdsWnhEXzM1WlB4SjZhVGU4N25HYWM4alVVLWplbE0yWFBkSTlPQVQ5bkgtVG56Y0Z5VVlvWGUzZVEzM3BPZGYtcG9BejNuek4tOHZCbTFnamJETllLbUJkOXVvRkdva19vZDdxQ19oemxySDNQWWVES1k?oc=5","date":"2026-03-03","type":"deal","source":"businesswire.com","summary":"Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders - businesswire.com","headline":"Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPQUpHTWR6OFpJdmd5LXN5VkpsaVFqZGtvcFg3WnJNaXNmek5rY05yMXlvQk5GRGh2TE56Rlp4R0lDUXNKdUFCc3BSR3k0a3RpV1dqTmFid3Flb0kyTkpSMG5KUENsdHdJT0NiZVVzMGFvaDV5enk0MjVIR2ZzUm9GQ3ZMcmFmQmZoMGhpbmtjSQ?oc=5","date":"2026-01-28","type":"deal","source":"Pharmaceutical Technology","summary":"Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies - Pharmaceutical Technology","headline":"Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNQUZQUy1DTGJENnAtX29vSVhBQ3pCZzY0QnpwMkZSU3dyYUNmU254LU1LdTF2Wk4yUElQaUNWVWRaVW1FSW1jUlZZdnVMUnZIYllIdENsLWhwZ3c2TUdMeV9DUDBucFdGdkJ3LVFpQXdRbjNmcG1QZWQyU3Awa2NpMThhRG9fcE5rRWMxaXVSOWlBdmNCek9EVU9UWVRpa0IzbFgxejc0X29rcmlCN2wtNVZZWTQ0RDdEVEVmX2RiTlFMYWhBVEczVk16dVVUUjk2NUhfcmtWVk1uSDBiVk5td2JoRjFvWERGUC0yOUpfN2hWUDNHLVRpM2xYRUZfR1lwUGY0MjlCMWlJZHRPYlE?oc=5","date":"2026-01-27","type":"pipeline","source":"South China Morning Post","summary":"Biopharma innovator pioneers next-generation ‘One-pill Solution’ for cardiovascular–kidney–metabolic (CKM) diseases - South China Morning Post","headline":"Biopharma innovator pioneers next-generation ‘One-pill Solution’ for cardiovascular–kidney–metabolic (CKM) diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPRmtYZ3FyQmJ6WGplejNCTUJ2Q1ktcnc4Sk1TRk5WWGp0STBxUDY0ZFIzMGt6ajJPUmNVcUNkQW9sYmtDb05FZ3FycXhqQXNFVGF1VDJmWHlUa1NkeDZBSVNxaXQ3ZDRpMDVEZVJ5dzV2aFFuNW1HMHFLNjZxR3c4UTZDUQ?oc=5","date":"2026-01-26","type":"deal","source":"Insilico Medicine","summary":"Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies - Insilico Medicine","headline":"Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Car","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxQR1RKOW90Q0pON092MTNxMjdudlVuc1BZTmJUX3FNQVZiWEpGRTBhNWdkQ3VsQnU1bThDdXJWNk5mM1p5NFNkanJKbTBWc2tmUTRBT0kzYjBwbzU3UnpjRmxGMVRuM2JLZ0F0bXBTeldWcVFhNjhxSmlxcXUzWU41MEVVMHA1Z1BNMnBQZUFINUgwSFlhLWl5SDVmT3d3ZHNIbVpfZmpOOVVvM2RvOTZobXBvaC1ORzQwOGdsTzVZYU9HX1B3cHFkbkNuU2xra1FBZUl0Z3Z1VllBcFY2NGkwM0stbjNTRGZKdWgwUnRmZGl3cmktMmc0MFJjNXNNMFJtNDVKcnVhWEE5R2hFTE9yNDZMN25ybFNxek4td0JtM1hyQTA?oc=5","date":"2026-01-15","type":"pipeline","source":"businesswire.com","summary":"InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate for Metabolic Disease - businesswire.com","headline":"InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate f","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPTEx6THJnLUFseHpTdjhBdzNMTHRXZDZ2bWxJN19GQTdmWHVSa2RFRlo4ZHhPaVJyQzl4NDN2amxkbjBhWnVwU0NRZWp5elB2NVV1TEFBVHp2Mi0wWXdaTVRQMC02QU5mOG9RQ1pWdWRtdkYyTHVtSWJVMjg3NTE2STFGZWlIekU2cGVPMFdwUExGdEVtMi1GRWhfZjNVMWNrWHVvcmFFRW9oRDZYY04talFqS0RublctdEVqaG55TGVBV2tDOUE?oc=5","date":"2025-12-12","type":"deal","source":"Contract Pharma","summary":"Zealand Pharma, OTR Therapeutics Sign Deal to Develop Metabolic Disease Treatments - Contract Pharma","headline":"Zealand Pharma, OTR Therapeutics Sign Deal to Develop Metabolic Disease Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBsVWp4cEY3Z0U4X1ZwYVBnQUxRTW5Qbnl0clRMcXNZTDFScUpUTC1pZUlqNjdWNWFPT3FZRzFQbjJGcDB4SUMzUS1sZTNfLTc3bU1B?oc=5","date":"2025-12-11","type":"pipeline","source":"FirstWord Pharma","summary":"Zealand's ambitious plans to move beyond the 'weight-loss Olympics' - FirstWord Pharma","headline":"Zealand's ambitious plans to move beyond the 'weight-loss Olympics'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOd3lyYm54NUFmUnY4N2VlTndjazNSdjhqNFF4cHNwU3Ezb3RyLWVkcTlZQzhIeVF1dHZ1SC1LUzZtd2R6MlRraEtvZzRfc08ycWdwbFZ2elJZeWViV202UU1vbGVmSXlFLTNDZ29mMEtNcndVcC1YVTFIYXJyY19FejE2eGRfODc1QnpsaDJVRFp5bU5Sclhz?oc=5","date":"2025-11-18","type":"trial","source":"Yahoo Finance","summary":"Metabolic Disorders Therapeutics Market Poised to Grow from US$74.97 Billion in 2024 to US$157.65 Billion by 2033 | DataM Intelligence - Yahoo Finance","headline":"Metabolic Disorders Therapeutics Market Poised to Grow from US$74.97 Billion in 2024 to US$157.65 Billion by 2033 | Data","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxORkRmMWNMYmMxY0huZGZKbDRQRXpjeTA1MzBpZXBTbkJCTE9YdVlsaGhSMWVXU0labDNMdG5HLUtDY25DZURmZlFIaTNGckVYS3ZRT0p5TVBXd1E5Tk0wVE9Udm9iNG53bWJwSGlXOUlRSmtfSEZZekFHVkduaGUwbHd3Q21sMDNYWThBRUtiV2V0SF9YWXEzb3B4WWZiV1B1VTdGWlhZRS00enZLcHhoNU9BVmlTdUVoWnFsY1Jn?oc=5","date":"2025-11-02","type":"pipeline","source":"BioBuzz","summary":"Investing in the Future of Obesity Solutions and Health Tech - BioBuzz","headline":"Investing in the Future of Obesity Solutions and Health Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQeThtY2JnWEVsdnROZm95NFlxSEdfbHVSRjM0Zk5CT3RNbUg0aE1ibUtaZlVGQnh4eXpSZW9jUnZvaV80WTVNOTRXY1hRSUhiT0cxN19xdGQ5eFA2TG9icnJpUEc4UjIycWNRMDc2elJ6N1UxdHYtRnJjMmludXBtXzRfSGtFZEE?oc=5","date":"2025-08-26","type":"pipeline","source":"macquarie.com","summary":"Supporting a Hong Kong biotech IPO - macquarie.com","headline":"Supporting a Hong Kong biotech IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBTTFZmV09POFZlbDVfRU9GaGlEVjBfYll1ZUFSdzUzUnBsSFBDNVNqQ3poY3E4TDNUdy13QVh6RmowM2UtYkl2Q010RkxmakpZajYwb25HSXBsTnpHV0pLMzZjeXJWTTV6Nld0NW40cHlobXBfdFZUVUJ5UQ?oc=5","date":"2025-06-18","type":"pipeline","source":"Femtech Insider","summary":"Metabolic Health Company Veracity Raises $6M - Femtech Insider","headline":"Metabolic Health Company Veracity Raises $6M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQWXdCRTlYMjVZWGdYdERKckRMZ2Z4V25WcXdPbU83OC1FSTY5UF9NSFpyQlJvRksyYVpLVmkzeThMX0I4bzdUZ0dhYmpjVURlMVd4SkdPMGRlQ05WYzRHOXFTcC11T3laaUpVNzRYTGRiNkhPNEdGYmhuM0NMa3lELU95ei1yMGxPOFN2WjJWbUVzbDc2NDRUZ0puelNZM1BDTjN1bzJXU1NwVkFNYW50akhoTWFnNXRKNkVGWmR0TG9PQUtZQ3d0M0VrVzZYdw?oc=5","date":"2025-05-14","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Forge Biologics Inks AAV Development and cGMP Manufacturing Deal with Fractyl Health - Genetic Engineering and Biotechnology News","headline":"Forge Biologics Inks AAV Development and cGMP Manufacturing Deal with Fractyl Health","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}